Trelagliptin Succinate Intermedia CAS 865759-246 Puritas >98.0% (HPLC)

Description:

Trelagliptin Succinate Intermedia-int D

CAS: 865759-246

Puritas: >98.0% (HPLC)

Aspectus: Off-White ad lux Yellow Crystal

Medium Trelagliptin Succinatum (CAS: 1029877-94-8) pro curatione Typus 2 Diabete.

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Commercial Supple Trelagliptin Succinate Related Intermedia:
6-Chloro-3-Methyluracil CAS 4318-56-3
2-Cyano-5-Flurobenzyl Bromide CAS 421552-12-7
(R)-(-)-3-Aminopiperidine dihydrochloride CAS 334618-23-4
Trelagliptin Succinate Intermediate-int D CAS 865759-246
Trelagliptin Succinate CAS 1029877-94-8
Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum	Trelagliptin Succinate Intermedia-int D
Synonyma	2-((6-Chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile;2-[(6-Chloro-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl]-4-fluorobenzonitrile
immunditia	Trelagliptin Impuritas 17
Stock Status	In Stock, Commercial Scale
CAS Number	865759-24-6
Formulae hypotheticae	C13H9ClFN3O2
M. Pondus	293.68 g/mol
Density	1.49±0.10 g/cm3
Repono Nativ.	Refrigescant & siccum
COA & MSDS	Praesto
Brand	Ruifu Chemical

Specifications:

Items	Signa inspectionis	Proventus
Aspectus	Off-White ad lux Yellow Crystal	Conforms
Lepidium sativum
HPLC	Retention tempus test sample major apicem obtemperat vexillum referat	Conforms
IR - Infrared Imaginis	IR spectra spectra specimen et regula concordant	Conforms
inspicienda
Damnum in Siccatio	<0.50%	0.3%
Totalis immunditias	<2.00%	Conforms
Puritas / Analysis Methodus	>98.0% (HPLC)	99,1%
conclusio	Productum probatum & obsequitur cum specificationibus

Sarcina / at /naviportans:

Sarcina:Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Copia in vasis obsignatis in horreis frigidis et siccis et bene ventilatis ab substantiis non repugnantibus.A luce et humore protege.Fuge lucem;Airtight.
Naviportans:Libera ad orbem terrarum per FedEx / DHL Express.Ieiunium et certas traditiones provide.

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com

15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.

Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.

Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.

Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.

Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.

Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.

MOQ?Nec MOQ.Parvus ordo placet.

Tempus adferendi? Si intus prosapia, tres dies partus praestatur.

Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.

Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.

Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.

Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

Applicatio:

2-((6-chloro-3-Methyl-2,4-dioxo-3,4-dihydropyriMidin-1(2H)-yl)Methyl)-4-fluorobenzonitrile (CAS: 865759-24-6) adhibetur ut an. medium Trelagliptin Succinate (CAS: 1029877-94-8).Trelagliptin Succinatus, a Takeda, Iaponia, mense Martio 2015 emissus, sub commercio Zafatek nomine, ad genus 2 diabete tractandum adhibetur.Trelagliptin ultra-diu agens dipeptidylum peptidase IV (DPP-4) inhibitor per selective et continue inhibuit DPP-4 ad refrenandum sacchari sanguinis gradus.Trelagliptin primum medicamentum septimanale hypoglycemicum in foro est, et similes DPP-4 inhibitores in mercatu semel in die sumi necesse est.Zafatek medicamen commoda procul dubio commodius curationi aegris diabeticis bene providebit.Expectatur valde emendare commoditatem et obsequium aegrorum.die 26 Martii 2015, Iaponica gigas pharmaceuticus Takeda nuntiavit novum diabete medicamento Zafatek approbatum a Ministerio Iaponiae sanitatis, laboris et utilitatis (MHLW) pro curatione speciei 2 diabetarum.Approbatio notarum Zafatek factus est primum medicamentum hypoglycemicum oralis hebdomadalis in foro in mundo, et etiam in diabete foro ab Takeda delapsum repraesentat obstructoremque repraesentat.
Trelagliptin est dipeptidylum peptidase IV semel hebdomadale (DPP-4) inhibitor qui sanguinem saccharo moderatur per gradus selective et continue inhibito DPP-4.DPP-4 enzyma est quae inactivationem incretini (glucagon-amquam peptidis -1 (GLP-1) et glucoso-dependens, polypeptide insulinotropico (GIP) inchoare potest), quae in glucosi sanguinis constitutione magnas partes agunt.Inhibitio de DPP-4 potest augere sanguinem saccharo gradu secretionis insulinae-dependens, ita moderante gradu sanguinis saccharo.Submissio Trelagliptin NDA fundata est efficacia et salus data ex pluribus temporibus III clinicis iudiciis in patientibus Iaponica cum speciebus 2 diabete factis.Efficacia Trelagliptin in omnibus iudiciis confirmata est, et bonam salutem et tolerabilitatem habet.Administratio Trelagliptin semel in hebdomada efficaciter moderari potest sanguinem saccharo gradu et expectatur ad meliorem medicamentorum aegrorum obsequium.